Curis Lifesciences Ltd Share Price Today - Curis Lifesciences Ltd Stock Price Live NSE/BSE

Curis Lifesciences Ltd

NSE: CURIS BSE: 94348

₹99.90

(7.48%)

Wed, 08 Apr 2026, 09:20 am

MTF 5xInvest in Curis Lifesciences Ltd with 5x Leverage Buy with MTF

Market Cap743.77M

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Curis Lifesciences Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
77.61
Net Profit
6.11
P/B
0
Sector P/E
31.10
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
9.71
ROCE (Industry)
13
RONW (Industry)
12.31
ROE
55.32
ROCE
34.13
Debt/Equity
1.48
EPS (TTM)
6.63
Dividend Yield
0
Book Value
46.32
Interest Cover
8.45

Analysis

No Result Found

Financials

Ratios

Shareholders	JUN 2025	DEC 2024
Promoters	92.68	92.68
FII	0	0
DII	0	0
Public	7.32	7.32
Government	0	0

Technical Analysis

RSI

56.28

MACD

-1.45

50 DMA

101.05

200 DMA

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	124.98	108.58	100.77	92.18	84.37	75.78	59.38
Fibonacci	108.58	102.32	98.45	92.18	85.92	82.05	75.78
Camarilla	97.46	95.96	94.45	92.18	91.45	89.94	88.44

Pivots Level: Classic

+32.80

124.98

+16.40

108.58

+8.58

100.77

92.18

Pivot Point

LTP: 101.75

-7.82

84.37

-16.40

75.78

-32.80

59.38

Moving Average

SMAEMA

Period

Value

10-EMA
95.16
20-EMA
95.49
30-EMA
97.23
50-EMA
101.52
100-EMA
-
200-EMA
-

Announcement Date	Purpose	Action	Ex Date
04 Dec 2025	board-meetings	Half Yearly Results

Curis Lifesciences Ltd

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Lupin Ltd

Divis Laboratories Ltd

Curis Lifesciences Ltd About

Curis Lifesciences is the pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral Liquid, Sterile Ophthalmic Ointments.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2016

Headquarters

CEO

Dharmesh Dasharathbhai Patel

Employees

Contact

Website

https://curisls.com

info@curisls.com

Phone

+91 70965 58558

Location

PF-23 GIDC Sanand II, Industrial Estate, Ahmedabad, Gujarat, 382110

Year	History
2021	The Company received FDA Approval from Philippines.
2022	The Company renewed its WHO Certificates and received Nigeria NAFDAC Approval.
2023	The Company retained its FDA License for manufacturing Pharma products.
2024	The Company's status was changed to public limited and a fresh certificate of incorporation was issued on August 9, 2024. The name of the Company was changed from Curis Lifesciences Private Limited to Curis Lifesciences Limited via Special Resolution dated May 6, 2024.
2025	The Company was converted from Private Limited to Public Limited.

Client Name	Order Side	QTY	Avg Price	Date
RS SECURITIES	Sell	93000	95.05	06 Mar 2026
SIXTH SENSE SECURITIES PRIVATE LIMITED	Buy	93000	95.14	06 Mar 2026
VINEY GROWTH FUND	Sell	42000	129.15	05 Jan 2026
SS CORPORATE SECURITIES LIMITED	Buy	64000	129.55	05 Jan 2026
SS CORPORATE SECURITIES LIMITED	Buy	61000	116.54	26 Dec 2025
RADHU DEVELOPERS PRIVATE LIMITED	Buy	53000	143	14 Nov 2025
JAIN SANJAY POPATLAL	Buy	50000	146.1	14 Nov 2025
PREETI BHAUKA	Buy	120000	146.1	14 Nov 2025
SACHIN KAPOOR	Buy	50000	146.1	14 Nov 2025

Curis Lifesciences Ltd News

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800